Ichor Therapeutics
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
831 James St, Syracuse, New York, 13203,...Website
www.ichorlifesciences.comRevenue
$6.2 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
2
1
1
1
1
About Ichor Therapeutics
Ichor Life Sciences, Inc. is a pre-clinical contract research organization (CRO) based in the US, specializing in a wide range of services including protein expression, pharmacology, and clinical trial management. The company aims to support biotechnology and pharmaceutical companies in drug research and development by providing high-quality laboratory services and customized study designs. With a team of experienced scientists, Ichor emphasizes method robustness and experimental reproducibility to ensure the success of their clients' projects. Their innovative approach and commitment to quality make them a valuable partner in the scientific community.Explore more
Ichor Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ichor Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Ichor Therapeutics launches new products
Funding: Get notified immidiatlly once Ichor Therapeutics has new funding data
Click to see if Ichor Therapeutics had a recent Job posting/layoffs
Check out if Ichor Therapeutics is spiking on competitors!
Earning: See what the market has to say on Ichor Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Ichor Therapeutics
Check if Ichor Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Ichor Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Ichor Therapeutics
Compare insights from companies similar to Ichor Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ichor Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ichor Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ichor Therapeutics.
Ichor Therapeutics financials insights
Gather financial insights about Ichor Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Grant
$79K
2020
Debt
$350K
2021
Debt
$423K
Ichor Therapeutics Tech Stack
A closer look at the technologies used by Ichor Therapeutics
See more technologies
Ichor Therapeutics News & Media
Cypris Therapeutics Launches as Newest Ichor Life Sciences Portfolio Company, Secures Over $500k in Pre-Seed Funding
SYRACUSE, N.Y.--(BUSINESS WIRE)--Cypris Therapeutics, a drug discovery company, has launched following a breakthrough in synthetic chemistry technology which allows development of novel chemistries for treatment of therapeutically resistant diseases, including brain and pancreatic cancers. "At Cypris Therapeutics, we are driven by a mission to develop life-saving therapies for some of the deadliest and therapeutically challenging diseases," said Kyle Parella, PhD, Co-Founder and CEO at Cypris.Ichor Life Sciences Announces Launch of Ichor Clinical Trial Services
Ichor Life Sciences, a full-service contract research organization (CRO) and longevity biotechnology company, today announced the launch of Ichor Clinical Trial Services. With the founding of Ichor Clinical, the company is now able to serve biotechnology and pharmaceutical clients from...Ichor's Auctus Biologics Closes Quick $1.5MM
LAFAYETTE, N.Y.--(BUSINESS WIRE)--Auctus Biologics, Inc., a new portfolio company of Ichor Therapeutics, Inc., announced today the closure of $1.5MM in seed funding. The company will develop RPtag, a hyper-stable antibody mimetic scaffold published earlier this year in the peer-reviewed journal ACS Biochemistry, to take on conventional clinical antibody therapy as an orally bioavailable formulation. New high priority immunosenescence and gastrointestinal targets will also be pursued. "The RPtag
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Ichor Therapeutics
Sign Up For FreeTo access detailed company insights
Ichor Life Sciences, Inc. is a pre-clinical contract research organization (CRO) based in the US, specializing in a wide range of services including protein expression, pharmacology, and clinical trial management. The company aims to support biotechnology and pharmaceutical companies in drug research and development by providing high-quality labora... Read More
